Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Effectiveness of a Suicide Ideation Prevention Program: Reframe-IT+

NCT06759441 is registered in ClinicalTrials.gov with Universidad de los Andes, Chile as lead sponsor.

NCT NCT06759441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Effectiveness of a Suicide Ideation Prevention Program: Reframe-IT+
Lead sponsor
Universidad de los Andes, Chile
Phase
Not applicable
Overall status
Completed
Start date
June 3, 2024
Completion date
December 31, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, hopelessness, suicidal ideation